Vivus LLC, 65IB, 36F79726D0185, Performance Period: 09/29/2026 - 09/30/2031

Genzyme Corporation

Bausch Health US, LLC Award 09/30/2026 - 09/30/2031

Sumitomo Pharma America, Inc. 09/01/2026 - 08/31/2031

Sumitomo Pharma America, Inc. 09/01/2026 - 08/31/2031

Novum Medical Products of NY, LLC 65IIA, 36F79726D0188 Effective 9/1/2026/Expires 8/31/2031

Americare, LLC. 65IIA Base Period of Performance 09/01/2026 - 08/31/2031

VA GLA Pluvicto and Lutathera

FY27 F18 Florebetapir

Genzyme Corporation

Febuxostat Tablets

Piflufolastat F-18 injection drugs (Pylarify) from Lantheus (Notice of Intent to sole source)

Morphine Sulfate Solution

CON NRM 531-25-102 | Expand Emergency Room

Chiller Maintenance

Optical Amplifiers

Bloomberg Terminal Licenses

Brand Name IBML Fusion 8300

USMS Security Upgrades at the El Centro Courthouse